49th week of 2009 patent applcation highlights part 58 |
Patent application number | Title | Published |
20090298878 | OXIME COMPOUNDS AND THE USE THEREOF - The invention relates to oxime compounds of Formula (I) and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein X is hydrogen, optionally substituted aryl, optionally substituted heteroaryl or the like; Y is CO, SO | 2009-12-03 |
20090298879 | Impurities of Donepezil - The present invention relates to impurities of donepezil, or a pharmaceutically acceptable salt thereof, which may be produced during synthesis and storage of donepezil, or a pharmaceutically-acceptable salt thereof, and to methods of identifying such impurities. The invention also relates to the use of these impurities in analytical techniques and to product that contain certain low levels of these impurities in particular the following impurities are disclosed: formula (I) and formula (II). | 2009-12-03 |
20090298880 | METHODS FOR THE ADMINISTRATION OF ILOPERIDONE - The present invention relates to methods for the identification of genetic polymorphisms that may be associated with a risk for QT prolongation after treatment with iloperidone and related methods of administering iloperidone to patients with such polymorphisms. | 2009-12-03 |
20090298881 | Water-Soluble Artemisinin Derivatives, Their Preparation Methods, the Pharmaceutical Compositions and the Use Thereof - Water-soluble artemisinin derivatives, their preparation methods, the pharmaceutical compositions containing the same derivatives and the use thereof are disclosed. The artemisinin derivatives have following formula I. It has been proved by pharmacological tests that these compounds and compositions have evident immuno-suppressive activities, and may be used in the preparation of novel immuno-suppressants for treating the diseases caused by hyperfunction of human immunity (e.g. the auto-immune diseases such as lupus erythematosus, rheumatoid arthritis, multiple sclerosis and the like), and for inhibiting the graft rejection after cell or organ transplantation. | 2009-12-03 |
20090298882 | THIOXOISOINDOLINE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME - Provided are thioxo isoindoline compounds, and pharmaceutically acceptable salts, solvates, and stereoisomers, thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed. | 2009-12-03 |
20090298883 | N-PIPERIDINYL ACETAMIDE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS - Methods and compounds effective in ameliorating conditions characterized by unwanted calcium channel activity, particularly unwanted T-type calcium channel activity are disclosed. Specifically, a series of compounds containing N-piperidinyl acetamide derivatives as shown in formula (1). | 2009-12-03 |
20090298884 | Esomeprazole Strontium Salt, Process For Its Preparation and Pharmaceutical Compositions Containing Same - A strontium salt of esomeprazole is provided. A process for preparing a strontium salt of esomeprazole is also provided comprising reacting esomeprazole free base or a sodium, potassium or lithium salt of esomeprazole with a strontium source in one or more solvents. | 2009-12-03 |
20090298885 | METHYLENE UREA DERIVATIVES - The present invention relates to methylene urea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient. | 2009-12-03 |
20090298886 | 2-INDOLINONE DERIVATIVES AS MULTI-TARGET PROTEIN KINASE INHIBITORS AND HISTONE DEACETYLASE INHIBITORS - The present invention relates to 2-indolinone derivatives which are capable of inhibiting protein kinases and histone deacetylases. The compounds of this invention are therefore useful in treating diseases associated with abnormal protein kinase activities or abnormal histone deacetylase activities. Pharmaceutical compositions comprising these compounds, methods of treating diseases utilizing pharmaceutical compositions comprising these compounds, and methods of preparing these compounds are also disclosed. | 2009-12-03 |
20090298887 | METHOD FOR IMPROVING HARVESTED SEED QUALITY - The present invention is directed to a method for improving the quality of seeds harvested from seed-producing plants. The method comprises treating the pre-planted seeds of the seed-producing plants with a seed treatment insecticide and treating the resulting plant with foliar applications of a foliar insecticide; or treating the pre-planted seeds of the seed-producing plants with a seed treatment insecticide; or treating seed-producing plants with foliar applications of a foliar insecticide. | 2009-12-03 |
20090298888 | Method of improving plant development and increasing the resistance of plants to soil-borne harmful fungi - The present invention relates to a method of improving plant growth and increasing the resistance of plants to soil-borne harmful fungi by directly admixing neonicotinoid-containing formulations into nutrient solutions conventionally employed in raising plants. | 2009-12-03 |
20090298889 | PHARMACEUTICAL COMPOSITIONS CONTAINING 2-PYRIDONE DERIVATIVES AS EFFECTIVE COMPONENTS - The present invention herein provides a 2-pyridone derivative which has a cell adhesion-inhibitory activity and which is useful for preventing and/or treating pathema or disease conditions including, for instance, inflammations which relate to leukocytic infiltration. The 2-pyridone derivative is a compound represented by the following general formula (1). In the formula, R | 2009-12-03 |
20090298890 | NEW N-METHYL BENZAMIDE DERIVATIVES - A compound of general formula (I): | 2009-12-03 |
20090298891 | Methods of Treating or Preventing Cancer Using Pyridine Carboxaldehyde Pyridine Thiosemicarbazone Radiosensitizing Agents - The present invention features methods of inhibiting ribonucleotide reductase and DNA synthesis after administration of a dose of ionizing radiation to cells. The present invention further features methods of treating patients suffering from cancer comprising contemporaneous or sequential administration of a radiosensitizing dose of a 2-carboxyaldehyde pyridine thiosemicarbazone compound and ionizing radiation. | 2009-12-03 |
20090298892 | Treatment Methods Employing Histamine H3 Receptor Antagonists, Including Betahistine - Methods of treating depression, binge eating disorder, narcolepsy, excessive daytime sleepiness, substance use disorders, and Prader Willi syndrome, disorders characterized at least in part by hypocortisolemia and decreased activity of the hypothalamic-pituitary-adrenal (HPA) axis, and disorders related to disturbances in circadian rhythm, comprising the step of administering an effective amount of a histamine type 3 (Bb) receptor antagonist, such as betahistine or its pharmaceutically acceptable salts, or its metabolites to an individual. | 2009-12-03 |
20090298893 | Addition Salts of Tolperisone, Processes for Their Preparation and Use Thereof - Addition salts of 2,4′-dimethyl-3-piperidinopropiophenone (tolperisone) are described, wherein the salt is formed with an acid R—COOH and wherein R is the organic group of a physiologically compatible organic acid. Described also are processes for the preparation of these addition salts, the use thereof for pharmaceutical preparations and pharmaceuticals containing these addition salts. | 2009-12-03 |
20090298894 | AMINO ACID COMPOUNDS - [Problem] To provide novel compounds that are S1P1 receptor agonists and exhibit an immunosuppressive activities by inducing lymphocyte sequestration in secondary lymphoid tissues. In addition, to provide a pharmaceutical agent which comprises the compounds as an effective component, in particular to provide a therapeutic and/or prophylactic agent for an autoimmune disease and the like. | 2009-12-03 |
20090298895 | USE OF THIOPROLINE IN BODY WEIGHT REDUCTION TREATMENTS - The invention relates to thioproline, pharmaceutically acceptable salts and/or prodrugs thereof that can be used as anorexia-inducing agents in both therapeutic and cosmetic treatments to reduce body weight. | 2009-12-03 |
20090298896 | ACTIVATING AGENT FOR PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA - A compound represented by the following general formula (II) or a salt thereof is used as an activator of PPARδ. | 2009-12-03 |
20090298897 | Treatment of Inflammatory Disorders With Triazole Compounds - The present invention relates to the use of triazole compounds for reducing inflammation and treating inflammation-associated disorders. | 2009-12-03 |
20090298898 | PESTICIDALLY ACTIVE KETONE AND OXIME DERIVATIVES - Compounds of formula | 2009-12-03 |
20090298899 | EP2 RECEPTOR AGONISTS - The disclosure provides EP | 2009-12-03 |
20090298900 | Oxo-Imidazolyl Compounds - Compounds represented by Formula I and II, or pharmaceutically acceptable salts thereof: | 2009-12-03 |
20090298901 | (E)-1-(4-((1R,2S,3R)-1,2,3,4-TETRAHYDROXYBUTYL)-1H-IMIDAZOL-2-YL)ETHANONE OXIME DIHYDRATE AND METHODS OF ITS USE - (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)-ethanone oxime dihydrate, compositions comprising it, and methods of its use are disclosed. | 2009-12-03 |
20090298902 | PESTICIDE COMPOSITIONS FOR COMBATING ARTHROPOD PESTS, SNAILS AND NEMATODES - The present invention relates to a pesticide composition in the form of a water absorbent granular material and to the use of such compositions for combating arthropod pests, in particular soil-living arthropod pests, and nematodes, with particular preference given to soil-living insect pests. The pesticide composition according to the invention as a water absorbent granular material, which contains: i) from 0.001 to 10% by weight of at least one pesticide compound, in particular a pesticide compound that is active against said soil-living arthropod pest, ii) from 80 to 99.999% by weight of at least one granular super absorbent polymer, and iii) water, wherein the % by weight are based on the total weight of the composition, except for water and wherein the components i) and ii) make up at least 90% by weight of the composition except for water, and wherein the water absorbent granular material is obtainable by a process which comprises the treatment of superabsorbent polymer granules with a liquid aqueous composition containing the at least one pesticide compound. | 2009-12-03 |
20090298903 | USE OF TETRAMIC ACID DERIVATIVES FOR INSECT CONTROL - An improved miniature portable child's training toilet comprises a first chamber with a toilet seat opening, a second chamber connected thereto, and a flap member at a connection point. A miniaturized tank portion with valve means and means of selectively causing the valve to open, allows fluid from the tank to move under gravity to the first chamber and continue into the second chamber, flushing material into the second chamber of the toilet. A means of separating the first and second chambers of the toilet for emptying the second chamber after flushing comprises a gasket for sealing the junction of the chambers. An electronic sound and light producing means plays congratulatory sounds and causes the toilet to illuminate when flushed. An alternate embodiment further comprises an “S” bend connecting the chambers, forming a water trap, and causing siphon action when the toilet is flushed. | 2009-12-03 |
20090298904 | NOVEL PEPTIDES FROM ACTINOMADURA NAMIBIENSIS - The disclosure relates to a compound of the formula (I) | 2009-12-03 |
20090298905 | Nitrogenatd trans-stilbene analogs, method for the obtention and medical applications thereof - This invention is related to new nitrogenated trans-stilbene analog compounds, more specifically, imine, pyrrol and Indole derivatives, with procedures for the preparation and use thereof as pharmaceutical compositions for the treatment and/or chemoprevention of those mammalian diseases such as cancer, fibrosclerosis and acute/chronic inflammation, graft-versus-host reaction, ischemic-reperfusion tissue injury in stroke and heart attack, neurodegeneration, and during organ transplantation, whose pathogenic and pathophysiological mechanisms depend on or are significantly contributed by undesirable oxidative stress, angiogenic and proliferative responses. | 2009-12-03 |
20090298906 | PROTEASOME INHIBITORS - Disclosed herein are compounds of Formula (I) that include a sulfonate ester, ester or ether group. Compounds of Formula (I) can be included in pharmaceutical compositions, and can be used to treating and/or ameliorating a disease or condition, such as cancer, a microbial disease and/or inflammation. | 2009-12-03 |
20090298907 | METHOD FOR THE PREPARATION OF 4-FLUORO-ALPHA-[2-METHYL-1-OXOPROPYL]-y-OXO-N-BETA-DIPHENYLBENZENEBUTANAM- IDE AND PRODUCTS THEREFROM - A method for the preparation of 4-fluoro-α-[2-methyl-1-oxopropyl]-y-oxo-N-β-diphenylbenzenebutanamide also known as 2-[2-(4-fluorophenyl)-2-oxo-1-phenylethyl]-4-methyl-3-oxo-pentanoic acid phenylamide of the formula I containing about 0.1% or less of α-[2-methyl-1-oxopropyl]-γ-oxo-N-p-diphenylbenzene butanamide, about 0.05% or less of difluoro-α-[2-methyl-1-oxopropyl]-y-oxo-N-β-diphenylbenzene butanamide and about 0.1% or less of 3-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-ethoxy]-4-methyl-pent-2-enoic acid phenylamide. | 2009-12-03 |
20090298908 | DMAE AS SOLE AGENT FOR THE TREATMENT OF MILD COGNITIVE IMPAIRMENT - The present invention relates to the use, as sole active ingredient, of dimethylaminoethanol (DMAE) in free form or in the form of salts or of esters and also of hydrates and solvates thereof, for the manufacture of a medicament for use in the treatment of a non-dementia mild cognitive impairment characterized by an amnestic syndrome of hippocampal type. | 2009-12-03 |
20090298909 | Multiple RNA Polymerase III Promoter Expression Constructs - Expression constructs comprising at least two different RNA polymerase III promoters, wherein each promoter is operably linked to a nucleic acid sequence encoding an RNA effector molecule, are disclosed herein. Further provided are expression constructs comprising multiple polymerase III promoters operably linked to sequences encoding short hairpin RNA molecules, which may comprise single and/or multiple fingers. The provided constructs are useful for in vivo delivery of RNA molecules effective in gene silencing, including of viral genes including HBV and HCV. | 2009-12-03 |
20090298910 | REGULATION OF EPIGENETIC CONTROL OF GENE EXPRESSION - Methods are provided for the identification of compounds that selectively modulate epigenetic changes in gene expression. Compounds, compositions, kits or assays devices, and methods are provided for modulating the expression, endogenous levels or the function of small non-coding RNAs cognate to or transcribed by heterochromatic regions subject to epigenetic regulation (i.e., promoters, enhancers, centromeres, telomeres, origins of DNA replication, imprinted loci, or loci marked by dosage-compensation), and for modulating the formation or function of heterochromatin in cells, tissues or animals. | 2009-12-03 |
20090298911 | SIRNA HAVING ANTIVIRAL ACTIVITY AGAINST NONPOLIO ENTEROVIRUS - The present invention relates to an siRNA (small interfering RNA) having antiviral activity against nonpolio enteroviruses, and a pharmaceutical composition comprising same as an active ingredient for preventing and treating diseases caused by nonpolio enterovirus infection. | 2009-12-03 |
20090298912 | Arginase II: A Target treatment of aging heart and heart failure - The instant invention provides methods and compositions for the treatment of cardiac dysfunction. Specifically, the invention provides methods and compositions for modulating Arginase II for the treatment of cardiac dysfunction. | 2009-12-03 |
20090298913 | SMALL INTERFERING OLIGONUCLEOTIDES COMPRISING ARABINOSE MODIFIED NUCLEOTIDES - Small interfering ribonucleic acid duplexes that inhibit gene expression containing at least one arabinose modified nucleotide are provided. Preferably, the duplexes contain ribonucleotides at least one arabinose modified nucleotide is 2′-deoxy-2′-fluoroarabinonucleotide (FANA) nucleotide. | 2009-12-03 |
20090298914 | RNA Interference Mediated Inhibition of Severe Acute Respiratory Syndrome (SARS) Virus Gene Expression Using Short Interfering Nucleic Acid (siNA) - The present invention comprises compounds, compositions, and methods useful for modulating the expression of genes associated with respiratory and pulmonary disease, such as severe acute respiratory syndrome (SARS) virus genes, using short interfering nucleic acid (siNA) molecules. This invention also comprises compounds, compositions, and methods useful for modulating the expression and activity of SARS virus genes, or other genes involved in pathways of SARS virus gene expression and/or activity by RNA interference (RNAi) using small nucleic acid molecules. In particular, the instant invention features small nucleic acid molecules, such as short interfering nucleic acid (siNA), short interfering RNA (siRNA), double-stranded RNA (dsRNA), micro-RNA (miRNA), and short hairpin RNA (shRNA) molecules and methods used to modulate the expression of SARS virus RNA. | 2009-12-03 |
20090298915 | TOPICAL DRUG DELIVERY - Poly-pseudo-lysine conjugates have been shown to be able to penetrate into human skin and are proposed for both therapeutic and cosmetic treatments by topical application, e.g. change of skin pigmentation. | 2009-12-03 |
20090298916 | Pharmaceutical compositions for treatment of microRNA related diseases - The present invention provides compositions and methods of treatment of diseases that are sensitive to drugs that downregulate the function of microRNA's, mRNA, non-coding RNA, or viral genomes. In particular, it has been discovered that a very long term effect of an anti microRNA oligonucleotide may be obtained when administered to a primate. Therefore, the present invention relate to pharmaceutical compositions and methods for treatment of primates, including humans wherein the compositions are administered with a long time interval. | 2009-12-03 |
20090298917 | Non-Viral Vector System For The Delivery Of Nucleic Acid Into The Lung - The present invention related to a non-viral vector system for the delivery of nucleic acids which is modified on the basis of polyethylene imine (PEI) with polyethylene glycol (PEG) and which contains a peptide sequence with PTD/CPP-functionality. | 2009-12-03 |
20090298918 | Alternative Splicing Isoform of Lox-I Protein Encoding Gene, and Uses Thereof - The invention relates to a new alternative splicing isoform of OLR1 gene encoding for the LOX-1 protein, uses and methods related to the treatment and to the prediction of the risk of cardiovascular diseases. | 2009-12-03 |
20090298919 | Tumor homing molecules, conjugates derived therefrom, and methods of using same - The present invention provides tumor homing molecules, which selectively home to a tumor. The invention also provides methods of using a tumor homing molecule to target an agent such as a drug to a selected tumor or to identify the target molecule expressed by the tumor. The invention also provides methods of targeting a tumor containing angiogenic vasculature by contacting the tumor with a molecule that specifically binds an α | 2009-12-03 |
20090298920 | CHIMERIC TRANSFER RNA AND USE THEREOF FOR THE PRODUCTION OF RNA BY A CELL - The present invention relates to the use of a nucleic acid encoding a chimeric transfer RNA (tRNA), which chimeric tRNA originates from the modification of a tRNA by insertion of an RNA into the stem-loop of the anticodon of the tRNA and/or by substitution of all or part of the stem-loop of the anticodon of the tRNA with an RNA, for the production of the RNA or of a part of the RNA, in a cell. | 2009-12-03 |
20090298921 | METHODS AND COMPOSITIONS FOR USE IN HOMOLOGOUS RECOMBINATION - Methods for homologously recombining an exogenous nucleic acid into a target cell genome of a target cell are provided. In the subject methods, a targeting vector that includes a linearizing endonuclease site, e.g., a recombinase recognition site, and a homologous recombination integrating element, is contacted with the target cell(s) such that the target cell(s) take up the targeting vector. The targeting vector is originally a circular targeting vector that is linearized by a linearizing endonuclease, e.g., a recombinase, either prior to administration (e.g., in vitro treatment with an endonuclease) or upon entry into the multicellular organism by endonucleases in the extracellular or intracellular fluids that can be introduced to or already present in the muticellular organism. The integrating element homologously recombines into the target cell genome from the linearized targeting vector. Also provided are targeting vectors, systems and kits for use in practicing the subject methods. | 2009-12-03 |
20090298922 | AAV TRANSDUCTION OF MUSCLE TISSUE - A method of expressing a gene product in the muscle tissue of an animal, which comprises administering a recombinant AAV vector to the muscle tissue of the animal, wherein the vector comprises a non-AAV gene of interest ligated into an AAV vector genome. | 2009-12-03 |
20090298923 | Salicylate Conjugates Useful for Treating Metabolic Disorders - The present invention is directed to methods for treating metabolic disorders with compounds that are conjugates. The conjugates of the present invention are comprised of salicylic acid, triflusal, diflusinal, salsalate, IMD-0354, ibuprofen, diclofenac, licofelone, or HTB, and one or more antioxidants. | 2009-12-03 |
20090298924 | HYDROXAMIC ACID DERIVATIVES AS INHIBITORS OF HDAC ENZYMATIC ACTIVITY - Compounds of formula (I) are inhibitors of histone deacetylase activity, and are useful in the treatment of, for example, cancers: | 2009-12-03 |
20090298925 | SUBSTITUTED BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR-BETA AGONISTS - The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof useful as Estrogen Receptor beta agonists for treating Estrogen Receptor beta mediated diseases such as benign prostatic hyperplasia. | 2009-12-03 |
20090298926 | PROCESS FOR THE PURIFICATION 10-DEACETYBACCATINE III FROM 10-DEACETYL-2-DEBENZOYL-2-PENTENOYLBACCATINE III - A process for the preparation of 10-deacetyl-7,10-bis-trichloroacetylbaccatine III with HPLC purity higher than 99% and free from 2-debenzoyl-2-pentenoylbaccatine III by purification of 10-deacetyl-7,10-bis-trichloroacetylbaccatineIII followed by alkaline hydrolysis of the protecting groups in position | 2009-12-03 |
20090298927 | Thermal Extraction Method and Product - The present invention is related to a thermal extract of a plant material and methods of extraction thereof. The method of producing a thermal extract from a plant starting material by means of a thermal extraction of the starting material wherein the improvement consists in requiring smaller amounts of costly and/or toxic organic solvents for the extraction and partitioning steps. | 2009-12-03 |
20090298928 | COMPOSITION AND METHOD FOR SCALP AND HAIR TREATMENT - Provided is a composition for scalp and hair treatment, comprising a menthol derivative and a prostaglandin compound having two hetero atoms at the 15 position. The composition of the present invention is effective not only for preventing dandruff and itchy scalp but also for preventing or treating hair loss, baldness, or hair thinness. | 2009-12-03 |
20090298929 | NOVEL NATURAL CYCLODEXTRIN COMPLEXES - The present invention is directed to the novel use of complexes of cyclodextrin. In particular the invention is directed to a complex of a cyclodextrin selected from the group consisting of α-CD, β-CD and γ-CD and a cannabinoid selected from the classical cannabinoid-group consisting of canabinol, tetrahydrocanabinol and canabidiol. | 2009-12-03 |
20090298930 | Methods For Purifying Trans-(-) Delta9-Tetrahydrocannabinol And Trans-(+)-Delta9-Tetrahydrocannabinol - Methods for making trans-(−)-Δ | 2009-12-03 |
20090298931 | NOVEL CHROMENONE POTASSIUM CHANNEL BLOCKERS AND USES THEREOF - The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation. | 2009-12-03 |
20090298932 | COMPOSITION AND METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS - The composition for treating neurological disorders such as Alzheimer's Disease is provided. The composition includes a modified flavonoid compound having enhanced binding affinity to metabolic modulating enzymes. The composition is effective to down-regulate beta- and gamma-secretase and up-regulate alpha secretase, which results in a reduction in amyloid proteins. | 2009-12-03 |
20090298933 | ORAL COMPOSITION CONTAINING EGCG AND LYCOPENE - Composition containing the combination of (−)-epigallocatechin gallate (EGCG) and lycopene characterized in that the ratio of EGCG to lycopene is in the range of 100:1 to 1:1. | 2009-12-03 |
20090298934 | Diamidine Inhibitors of TDP1 - The instant invention is directed towards compounds, including diamidines, that inhibit Tdp1 and are useful in the treatment and/or prevention of cancer and parasitic disease. | 2009-12-03 |
20090298935 | Production And Use Of A Gaseous Vapor Disinfectant - Smoke or vapor generating system disperses an airborne biocidal oil, such as methyl soyate, to decontaminate and area or object. The airborne forms of methyl soyate are have broad spectrum efficacy against a wide variety of microscopic pathogens including viruses, bacteria and fungi. | 2009-12-03 |
20090298936 | METHOD FOR ENERGIZING HUMAN BEINGS - The present invention relates to a method for energizing a human being and to administering an energizing (personal care) composition to human beings wherein said composition contains one or more fragrance materials of group (a) of the present invention. | 2009-12-03 |
20090298937 | Method for Inhibiting the Growth of Bacteria - The present invention is directed to a method for inhibiting the growth of pathogenic bacteria in an infant formula comprising supplementing the infant formula with at least one diglyceride antimicrobial agent. | 2009-12-03 |
20090298938 | USE OF SEMI SYNTHETIC ANALOGUES OF BOSWELLIC ACIDS FOR ANTICANCER ACTIVITY - The present invention relates to use of compounds of general formula 1 for anticancerous activity, wherein the said compound being derived semi-synthetically from natural triterpenoic acids known as boswellic acids by the induction of apoptosis thereof cytotoxicity and anti-cancer activity displayed by semi-synthetic analogues of natural triterpenes, known as Boswellic acids. These compounds may be used for the treatment of cancer, alone or in combination with pharmaceutically acceptable or other carriers, displaying cytotoxicity and anti-cancer activity for colon, prostrate, liver, breast, central nervous system (CNS), leukemia and malignancy of other tissues, including ascites and solid tumors. The cancer cell death is mediated by induction of apoptosis and inhibition of cell proliferation at specific doses. | 2009-12-03 |
20090298939 | Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals - The disclosure provides a method for isolating the bioactive component of the water-soluble extract of | 2009-12-03 |
20090298940 | All Natural Antifungal And Antimicrobial Composition And Method Thereof - In accordance with the present invention, there is provided a novel all natural antifungal composition and method. There is further provided a novel all natural antibiotic and antimicrobial composition and method. There is provided an antifungal and/or antimicrobial composition and method that may be used to treat conditions caused by gram negative bacteria, viruses and fungi, especially molds and mycocytes, with a composition comprising potassium sorbate, lecithin, cellulose, and wax. There is provided a composition and method for administration directly to dermal, oral, gastrointestinal and/or nasal tissues that are affected by molds and mycocytes. | 2009-12-03 |
20090298941 | ANTI-ADIPOCYTE FATTY ACID-BINDING PROTEIN (AP2), ANTI-FLAP AND ANTI-CYSLT1 RECEPTOR HERBAL COMPOSITIONS - Herbal compositions having anti-adipocyte fatty acid-binding protein (aP2), anti-5-lipoxygenase-activating protein (FLAP) and anti-Cysteinyl Leukotriene (CysLT)-1 receptor expression activity contain an extract of | 2009-12-03 |
20090298942 | ANIMAL COMPOSITION - The present invention relates to a composition which delivers an amount of leucine sufficient to enhance the learning ability of an animal. The present invention also relates to a food supplement for enhancing the learning ability of an animal and to methods for enhancing such learning ability. | 2009-12-03 |
20090298943 | Use of creatine analogues and creatine kinase modulators for the prevention and treatment of obesity and its related disorders - The present invention relates to the use of creatine compounds for treating or preventing a metabolic disorder related to body weight control such as obesity, and it's associated diseases in a patient experiencing said disorder. The creatine compounds which can be used in the present method include (1) analogues of creatine which can act as substrates or substrate analogues for the enzyme creatine kinase; (2) compounds which can act as inhibitors of creatine kinase; (3) compounds which can modulate the creatine transporter (4) N-phosphocreatine analogues bearing transferable or non-transferable moieties which mimic the N-phosphoryl group. (5) compounds which modify the association of creatine kinase with other cellular components. | 2009-12-03 |
20090298944 | PHARMACEUTICAL COMPOSITION - The present invention relates to a pharmaceutical composition of practically water insoluble or low water soluble compounds containing catechol moiety by enhancing the solubility of such compounds using one or more alkalising agent and optionally adding one or more pharmaceutically acceptable excipient. The present invention also relates to a process for preparing such pharmaceutical composition | 2009-12-03 |
20090298945 | Aqueous Extracts from Monocotyledon Plants and Their Use in Cardioprotection - Method of treating hypertension with a trans-aconitic acid containing composition (e.g., a water extract derived from a monocotyledon plant). | 2009-12-03 |
20090298946 | Local Anesthetic Deactivation - A chemical solution for deactivating the effects of local anesthetic is disclosed. Local anesthetic is important in many medical procedures, such as dentistry, surgical procedures, and veterinary medicine. In many cases, after the procedure has been completed, the need for blocking the nerve conductance is no longer needed or wanted, and the effects of local anesthesia can last for several hours post procedure. This invention works by two mechanisms, manipulating the pH and calcium concentration of the local cellular environment. The invention can be delivered via an oral transmucosal delivery device or via an injectable. It provides a safe and biologically acceptable means to quickly eliminate the effects of local anesthetic. The use of this invention will allow patients to quickly gain back their normal nerve function. | 2009-12-03 |
20090298947 | POLYMORPHIC AND AMORPHOUS FORMS OF LACOSAMIDE AND AMORPHOUS COMPOSITIONS - The present invention relates to polymorphic and amorphous forms of Lacosamide, processes of preparing the polymorphic and amorphous forms, pharmaceutical compositions containing the same, therapeutic uses thereof and methods of treatment employing the same. | 2009-12-03 |
20090298948 | COLCHICINE COMPOSITIONS AND METHODS - Stable ultrapure colchicine compositions comprising ultrapure colchicine and a pharmaceutically acceptable excipient are described. The compositions can be tablets. Methods for preparing such compositions and methods of use are also disclosed. Methods of treating gout flares with colchicine compositions are also disclosed. | 2009-12-03 |
20090298949 | AMINOALKYLPHENOLS, METHODS OF USING AND MAKING THE SAME - The present invention relates to Mannich base antimalarial aminoalkylphenol compounds and their use against protozoa of the genus | 2009-12-03 |
20090298950 | CYCLOPENTANE/CYCLOPENTENE ALDEHYDE OR KETONE DERIVATIVES AND THEIR USE AS ODORANTS - The present invention relates to campholytic aldehyde condensates of formula (I) | 2009-12-03 |
20090298951 | Nontoxic Biocidal Composition And Method Thereof - This invention discloses biocidal compositions and methods and more particularly, a novel nontoxic biocide and biostat composition and method for elimination and inhibition of gram negative bacteria (microorganism), viral, and/or fungal growth, especially molds. In one formulation, the novel biocidal composition is formed from equal amounts of potassium sorbate, lecithin, cellulose, and wax in a suspension with distilled mineralized water, preferably distilled mineralized water in combination with about 15% catalyst activated fluorine and chlorine free water. Using cellulose as a carrier for a wax to be ingested by a microorganism, fungal spore or virus is effective as a biocide because the ingested wax encapsulates the microorganism, fungal spore or virus, thereby effectively suffocating it. | 2009-12-03 |
20090298952 | PLATABLE SOLUBLE DYES - Edible colored powders are formed by combining silica with a soluble dye, such as a natural dye. The colored powders can be used to color edible substrates such as particles and compressed tablets. Methods of forming the edible colored powders may include a drying step to reduce the moisture content of the colored powder. | 2009-12-03 |
20090298953 | Drug delivery system and method of making the same - Disclosed is a method for making a composition which comprises of an array of unsaturated, aliphatic, biocompatible and biodegradable polyesters with photo curing capability which upon mixing with an active ingredient will provide an inject able liquid or putty-like material. The composition can be injected via a customary syringe and needle and be photocured in situ using visible light irradiation. Changing in the network crosslinking, molecular weight of the linear polymeric precursors and their chemical structures can control delivery rate of the active ingredient from the device. | 2009-12-03 |
20090298954 | Affinity Carrier and Method for Producing Thereof - An affinity carrier not of a particle aggregation type but in a gel state having a bicontinuous structure composed of pores having an average diameter of micrometer size arranged continuously in a three-dimensional network structure and a skeletal phase abundant in organic matters, comprising | 2009-12-03 |
20090298955 | ALTERED VIRUS CAPSID PROTEIN AND USE THEREOF - An altered capsid protein of a primate-infective papovavirus in which a foreign peptide sandwiched by 1 to several glycine residues at each end is inserted into at least one of the DE-loop or the HI-loop of the capsid protein of the primate-infective papovavirus, and a virus-like particle formed from the altered capsid protein. | 2009-12-03 |
20090298956 | SELF-PRESERVED EMULSIONS - The use of multifunctional synthetic compounds to both stabilize and preserve therapeutic emulsions is described. The multifunctional synthetic compounds have unique molecular arrangement wherein a phosphate group is linked to one, two or three quaternary ammonium functionalities via a substituted propenyl group, and each quaternary ammonium functionality is further linked to at least one hydrocarbon chain. The pharmaceutical emulsions which include these multifunctional compounds may be prepared without heating or homogenization, and may not require the use of any additional stabilizing or preserving agents. | 2009-12-03 |
20090298957 | METHOD AND INSTALLATION FOR COMBINED PRODUCTION OF HYDROGEN AND CARBON DIOXIDE - The invention concerns a method for combined production of hydrogen and carbon dioxide from a mixture of hydrocarbons wherein the residual PSA is treated to produce a carbon dioxide-enriched fluid, and wherein: the residual PSA is compressed to a pressure such that the partial pressure of the CO2 contained ranges between about 15 and 40 bar; the residue is subjected to one or more condensation/separation steps with production of CO2-rich condensate(s) and a purge of noncondensable gas; the purge of noncondensable gas is preferably treated to produce a H2-rich permeate which is recycled to the PSA, and a residue which is recycled to syngas generation, Preferably, the condensate(s) are purified by cryogenic distillation to produce food grade CO2. The invention also concerns an installation for implementing the method. | 2009-12-03 |
20090298958 | Fischer Tropsch Process - The present invention relates to a process for converting synthesis gas to hydrocarbons, in particular to hydrocarbons in the C5-C60 range particularly suitable for use as liquid motor fuels, in a slurry reactor in the presence of a Fischer-Tropsch catalyst comprising cobalt and zinc oxide wherein the Fischer-Tropsch catalyst is activated with a reducing gas consisting of hydrogen and an inert gas at 330 to 400° C. prior to contact with synthesis gas in the slurry reactor. | 2009-12-03 |
20090298959 | Polyurethane Resin Moulding For Vehicle Interior Part And Method Of Manufacturing The Same - A method of manufacturing a polyurethane resin moulding for a vehicle interior part, includes: adding at least one of a polyol mixture and a polyisocyanate compound to at least one of microencapsulated paraffin waxes and shirasu balloons, followed by polymerizing the polyol mixture and the polyisocyanate compound. The polyol mixture contains a polyol, a catalyst, a chain extender and an auxiliary agent. A melting point of the microencapsulated paraffin waxes is 60° C. to 80° C. | 2009-12-03 |
20090298960 | DUCTILE STRUCTURAL FOAMS - A composition containing at least one epoxy resin, at least one phenol compound that is solid at room temperature, at least one polyether amine, at least one propellant, at least one hardener, at least one filler suitable for manufacturing structural foams that are notable for ductile behavior under compressive or flexural loading, i.e. an elastic deformation is observed under compressive load or in the three-point flexural test. | 2009-12-03 |
20090298961 | MULTI-COMPONENT SYSTEMS, METHOD FOR THE PRODUCTION AND USE THEREOF - Multicomponent systems comprising | 2009-12-03 |
20090298962 | PHOTOLATENT BASES FOR SYSTEMS BASED ON BLOCKED ISOCYANATES - The present invention pertains to a composition comprising (a) a photolatent base; (b) a blocked isocyanate or blocked isothiocyanate and (c) a hydrogen donor compound; and its applications. | 2009-12-03 |
20090298963 | METHOD FOR PRODUCTION OF MODIFIED WATER ABSORBENT RESIN - This invention is to provide a method for producing a modified water absorbent resin excelling in water absorbing properties. This invention relates to a method for producing a modified water absorbent resin, which comprises a) mixing a water absorbent resin and a water-soluble radical polymerization initiator or a heat-degradable radical polymerization initiator without addition of an ethylenically unsaturated monomer and b) irradiating the resultant mixture with active energy rays. The method is particularly capable of exalting the absorbency against pressure and the saline flow conductivity. | 2009-12-03 |
20090298964 | Polyolefin-Based Crosslinked Articles - Methods for making a crosslinked elastomeric composition and articles made of the same are provided. In at least one specific embodiment, an elastomeric composition comprising at least one propylene-based polymer is blended with at least one component selected from the group consisting of multifunctional acrylates, multifunctional methacrylates, functionalized polybutadiene resins, functionalized cyanurate, and allyl isocyanurate; and blended with at least one component selected from the group consisting of hindered phenols, phosphites, and hindered amines. The propylene-based polymer can include propylene derived units and one or more dienes, and have a triad tacticity of from 50% to 99% and a heat of fusion of less than 80 J/g. The blended composition can then be extruded and crosslinked. The extruded polymer can be crosslinked using electron beam radiation having an e-beam dose of about 100 KGy or less. The crosslinked polymers are particularly useful for making fibers and films. | 2009-12-03 |
20090298965 | Highly heat-conductive epoxy resin composition - A highly heat-conductive epoxy resin composition, which comprises epoxy resin in a liquid state at room temperature, a latent curing agent, a highly heat-conductive filler, and a non-ionic surfactant, where preferably the latent curing agent is mixed with a portion of the epoxy resin in a liquid state at room temperature to form a master batch, can keep a relatively low viscosity, even if a large amount of the filler is contained, and can be cured at a relatively low temperature for a short time, and has a distinguished storage stability as one-component composition. | 2009-12-03 |
20090298966 | DENTAL MATERIAL - The dental material contains a polymerizable dental resin of index of refraction n | 2009-12-03 |
20090298967 | SELF DECONTAMINATING CHEMICAL AND BIOLOGICAL AGENT RESISTANT COATING - The disclosure provides for a self decontaminating coating and method. The coating comprises a polyurethane component having a solids content in the range of about 10 weight percent to about 100 weight percent and having at least one volume percent free space, a chemical active, and a biological active. In another disclosed embodiment, a method of reducing the transportation of chemical contaminants and biological contaminants is provided comprising the steps of providing a self decontaminating coating comprising a polyurethane component having a polyurethane component having a solids content in the range of about 10 weight percent to about 100 weight percent and having at least one volume percent free space, a chemical active, and a biological active, and applying the coating to a surface of an aircraft, rotorcraft, vehicle, item of equipment, or architectural structure. | 2009-12-03 |
20090298968 | DECORATIVE COMPOSITION AND METHOD OF USING IT - A composition includes a first filler in amounts of at least 50% based on the total composition weight and an optional second filler. Other components of the decorative composition include a polymeric resin, a coalescent solvent and water. This composition is substantially free of stucco, cement or other hydraulic component where the setting action would act as the binder for the composition. It is useful for creating textures on the surface of interior walls or ceilings. | 2009-12-03 |
20090298969 | CYANOACRYLATE COMPOSITIONS CONTAINING DISPERSIONS OF CORE SHELL RUBBERS IN (METH)ACRYLATES - The present invention provides a cyanoacrylate composition comprising a cyanoacrylate component; and a core shell rubber component having a particle size in the range of 3 nm to 1,000 nm dispersed in a curable (meth)acrylate matrix. | 2009-12-03 |
20090298970 | (METH)ACRYLATES COMPOSITIONS CONTAINING DISPERSIONS OF CORE SHELL RUBBERS IN (METH)ACRYLATES - The present invention provides a (meth)acrylate composition comprising a (meth)acrylate component; and a core shell rubber component having a particle size in the range of 3 nm to 1,000 nm dispersed in a curable (meth)acrylate matrix. | 2009-12-03 |
20090298971 | NOVEL WAX DISPERSION FORMULATIONS, METHOD OF PRODUCING SAME, AND USES - Aqueous wax dispersions useful as surface modifiers for paints, inks and coatings. More particularly, aqueous particulate wax dispersions useful as surface modifiers to provide improved properties in primers, paints, inks and other coating formulations. The dispersions are stable, substantially homogenous, have a high solids concentration at low viscosities, and comply with the applicable FDA regulations for use in food packaging applications. | 2009-12-03 |
20090298972 | Formulation for Obtaining a Translucent Concrete Mixture - A formulation for obtaining a translucent concrete mixture comprising a mixture of polycarbonate and epoxy matrices, as well as glass fibres, optical fibres, colloidal silica, silica and Portland cement. The invention has greater mechanical strength properties than those of a standard concrete, with lower density and mechanical characteristics that enable same to be used in both a structural and architectonic manner. The formulation used to obtain the translucent concrete mixture comprises a type of concrete that is different from those currently available, which combines the advantages of existing concretes with translucency. | 2009-12-03 |
20090298973 | Cement Admixture and Cement Composition Using Thereof - A cement admixture for concrete using a polycarboxylate based water reducing agent that can produce light concrete with little slump loss and good workability that prevents dragging and the like and having no material separation, and a cement composition using the cement admixture are provided. | 2009-12-03 |
20090298974 | COMPOSITE WITH NATURAL FIBERS - A polymeric composite material, and method of making the same, including a polymeric blend that includes at least one thermoplastic polymer; at least one functionalized polymer; at least one polyetheramine thermoplastic material; and a plurality of particles (e.g. naturally occurring organic materials) distributed substantially homogeneously throughout the polymeric blend. Articles employing such materials are also disclosed. | 2009-12-03 |
20090298975 | Synthetic Resins in Casein-Stabilized Rosin Size Emulsions - A process for forming a rosin-containing size emulsion for paper sizing, in which a basic aqueous first mixture containing at least partially saponified rosin is mixed with a basic aqueous dispersion of casein and formed into an oil-in-water emulsion, wherein an emulsion-stabilizing amount of a casein-compatible rosin-emulsifying synthetic resin is substituted for a portion of the casein, the portion being within a range of about 1-80% by weight of the casein. | 2009-12-03 |
20090298976 | Fiber-Reinforced Composition Resin Composition, Adhesive and Sealant - An object of the present invention is to provide a fiber-reinforced composite resin composition for use as a sealant, adhesive, or filler, having a high transparency, and enabled to adequately meet recently required levels of low thermal expansion property, high strength, light weight, high thermal conductivity, and especially high, isotropic thermal conductivity. With the fiber-reinforced composite resin composition, the fibers have an average fiber diameter of 4 to 200 nm, a total light transmittance at wavelengths of 400 to 700 nm as measured with a 50 μm-thickness cured product, resulting from curing the composition to a plate-like form, is no less than 70%, both a thermal conductivity coefficient in a thickness direction and a thermal conductivity coefficient in a plate surface direction of the cured product are no less than 0.4 W/m·K, and the fibers are oriented randomly in the composition. | 2009-12-03 |
20090298977 | Biodegradable Resin Composition, Production Method Therefor, and Product Molded or Formed Therefrom - A biodegradable resin composition is provided, which is highly transparent with little agglomeration. The biodegradable resin composition comprises a biodegradable polyester resin, a phyllosilicate, and at least one of a polyether phosphate compound, a polar wax and jojoba oil. | 2009-12-03 |